Recipharm races to India with Nitin


Recipharm, a Swedish contract development and manufacturing organization in the pharmaceutical sector, has signed an agreement to purchase 74% of the shares Nitin Lifesciences, an Indian sterile injectables contract manufacturing company.

You must be a subscriber to read this content, or you can register for free to enjoy the current issue.